DOW
62
2
GM
57
-6
MAS
34
-4
EFX
30
3
AIZ
61
5
MO
45
-2
TXT
70
-2
XYL
33
-2
CNP
70
2
AMGN
39
-5
FRT
45
2
MCO
56
3
FSLR
49
-3
BWA
55
-5
VRSN
66
4
PPG
53
-3
EXPE
54
-2
RF
61
3
CNX
48
4
STI
49
2
DOW
62
2
GM
57
-6
MAS
34
-4
EFX
30
3
AIZ
61
5
MO
45
-2
TXT
70
-2
XYL
33
-2
CNP
70
2
AMGN
39
-5
FRT
45
2
MCO
56
3
FSLR
49
-3
BWA
55
-5
VRSN
66
4
PPG
53
-3
EXPE
54
-2
RF
61
3
CNX
48
4
STI
49
2
Financhill
Back

Stillfront Group AB Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
40

STLFF
Stillfront Group AB

Last Price:
$0.43
Seasonality Move:
-3.86%
Buy
100

ORKA
Oruka Therapeutics, Inc.

Last Price:
$53.39
Seasonality Move:
5.42%
Sell
40
Stillfront Group AB (STLFF) is a Sell

Is Stillfront Group AB a Buy, Sell or Hold?

  • The current Stillfront Group AB [STLFF] share price is $0.43. The Score for STLFF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • STLFF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
100
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $53.31. The Score for ORKA is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ORKA is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

STLFF Stock Price Chart

What is Stillfront Group AB's stock price today?

  • The Stillfront Group AB share price today is $0.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLFF is experiencing slight buying pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $53.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing buying pressure, which is a positive indicator for future bullish movement.

STLFF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 4.95 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.44 - 0.5) Sell
Bollinger Bands (100): (0.49 - 0.67) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.1 Buy
Relative Strength Index (14 RSI): 77.59 Buy
Chaikin Money Flow: 1458349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 45.6) Buy
Bollinger Bands (100): (27.9 - 38.44) Buy

STLFF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.44 Sell
20-day SMA: 0.47 Sell
50-day SMA: 0.51 Sell
200-day SMA: 0.6 Sell
8-day EMA: 0.44 Sell
20-day EMA: 0.46 Sell
50-day EMA: 0.5 Sell
200-day EMA: 0.59 Sell

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Buy
20-day SMA: 41.09 Buy
50-day SMA: 36.64 Buy
200-day SMA: 25.3 Buy
8-day EMA: 47.34 Buy
20-day EMA: 42.69 Buy
50-day EMA: 37.82 Buy
200-day EMA: 28.4 Buy

Stillfront Group AB Earnings Growth & STLFF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.31 per share.

Stillfront Group AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):